Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,606 public trials 547 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse

NCT01087008

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hospital Universitari Germans Trias I Pujol Badalona, Spain
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
  • Hospital del Mar Barcelona, Spain
  • Hospital Vall d'Hebrón Barcelona, Spain
View all 16 locations
View Trial Details
Completed

Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation

NCT00031668

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +30 more
Locations
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
  • Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada
View Trial Details
Completed

Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis

NCT01318902

Conditions
Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations
  • Tufts Medical Center Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis

NCT01222260

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Tufts Medical Center Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Mt. Sinai Medical Center New York, United States
View Trial Details
Completed

Study of Ibrutinib in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed/Relapsed and Refractory Multiple Myeloma

NCT02902965

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Fakultní nemocnice Brno Brno, Czechia
  • Fakultní nemocnice Hradec Králové Nový Hradec Králové, Czechia
  • Fakultní nemocnice Ostrava Ostrava-Poruba, Czechia
  • Všeobecná fakultní nemocnice v Praha Prague, Czechia
View all 33 locations
View Trial Details
Completed

A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers

NCT01587703

Conditions
Blood Protein Disorders, Bronchial Neoplasms, Carcinoma, +31 more
Locations
  • GSK Investigational Site Baltimore, Maryland, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
  • GSK Investigational Site Nashville, Tennessee, United States
View all 17 locations
View Trial Details
Completed

Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma

NCT00918333

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +75 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mark O Hatfield-Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma

NCT01478581

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • SITE-13 La Jolla, California, United States
  • SITE-5 Baltimore, Maryland, United States
  • SITE-4 Boston, Massachusetts, United States
  • SITE-8 Ann Arbor, Michigan, United States
View Trial Details

Related conditions